Company

Abcuro

https://abcuro.com/

Industryclinical-stage biotechnology company developing therapies for the treatment of autoimmune diseases through precise modulation of cytotoxic T cells

Funding raised

CompanyRoundDate
AbcuroSeries D2026-08-18
AbcuroSeries C2025-02-13
AbcuroSeries B Financing2023-08-18